IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 1, 2008
(Investigative Ophthalmology and Visual Science. )
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.07-1505

This Article
Right arrow Full Text (P<P[PDF])
Right arrow All Versions of this Article:
iovs.07-1505v1
49/6/2651    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herrera, W.
Right arrow Articles by Jacobson, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herrera, W.
Right arrow Articles by Jacobson, S. G.

Article

Retinal Disease in Usher Syndrome III Caused by Mutations in the Clarin-1 Gene

Waldo Herrera 1, Tomas Aleman 1, Artur V. Cideciyan 1, Alejandro J Roman 1, Eyal Banin 2, Tamar Ben-Yosef 3, Leigh M. Gardner 1, Alexander Sumaroka 1, Elizabeth A.M. Windsor 1, Sharon B Schwartz 1, Edwin M. Stone 4, Xue-Zhong Liu 5, William J. Kimberling 6, and Samuel G. Jacobson 1*

1 Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, United States
2 Department of Ophthalmology, Hebrew University-Hadassah Medical School, Jerusalem, Israel
3 Department of Genetics and the Rappaport Family Institute for Research in the Medical Sciences, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
4 Howard Hughes Medical Institute and Department of Ophthalmology, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States
5 Department of Otolaryngology, University of Miami, Miami, Florida, United States
6 Department of Genetics, Usher Syndrome Center, Boys Town National Research Hospital, Omaha, Nebraska, United States

* To whom correspondence should be addressed. E-mail: jacobsos{at}mail.med.upenn.edu.


   Abstract

PURPOSE. To determine the retinal phenotype of Usher syndrome type III (USH3A) caused by clarin-1 (CLRN1) gene mutations in a non-Finnish population. METHODS. USH3A patients (n=13, ages 24-69) representing 11 different families were studied and results compared with those of USH2A (n=24, ages 17-66). Patients were evaluated by ocular examination, kinetic and static perimetry, near-infrared autofluorescence and optical coherence tomography (OCT). RESULTS. Ten of 11 families had Ashkenazi Jewish origins and the N48K CLRN1 mutation. Rod function was lost in the peripheral field in the first two decades of life but central rod function could be retained for another decade. Peripheral cone function was detectable into the third decade of life. Central cone function had a slower decline that extended for decades. Photoreceptor layer loss and features of retinal remodeling were present in retinal regions with severe visual dysfunction even at the youngest ages tested. Central retinal structure could be normal in younger patients but structural integrity was lost at increasing ages. RPE disease generally paralleled photoreceptor degeneration. Comparisons between USH3A and USH2A suggested a common rod and cone phenotype but a more accelerated time course of rod loss in USH3A. CONCLUSIONS. USH3A and USH2A share patterns of rod and cone dysfunction and retinal structural abnormalities. Based on peripheral function measurements, USH3A tended to be more rapidly progressive than USH2A.

Key Words: retinal degeneration, night vision, photoreceptor dystrophy, retinal dystrophy, retinitis pigmentosa, optical coherence tomography




This article has been cited by other articles:


Home page
IOVSHome page
S. G. Jacobson, A. J. Roman, T. S. Aleman, A. Sumaroka, W. Herrera, E. A. M. Windsor, L. A. Atkinson, S. B. Schwartz, J. D. Steinberg, and A. V. Cideciyan
Normal Central Retinal Function and Structure Preserved in Retinitis Pigmentosa
Invest. Ophthalmol. Vis. Sci., February 1, 2010; 51(2): 1079 - 1085.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. S. Aleman, N. Soumittra, A. V. Cideciyan, A. M. Sumaroka, V. L. Ramprasad, W. Herrera, E. A. M. Windsor, S. B. Schwartz, R. C. Russell, A. J. Roman, et al.
CERKL Mutations Cause an Autosomal Recessive Cone-Rod Dystrophy with Inner Retinopathy
Invest. Ophthalmol. Vis. Sci., December 1, 2009; 50(12): 5944 - 5954.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. Gibbs, A. V. Cideciyan, S. G. Jacobson, and D. S. Williams
Retinal Pigment Epithelium Defects in Humans and Mice with Mutations in MYO7A: Imaging Melanosome-Specific Autofluorescence
Invest. Ophthalmol. Vis. Sci., September 1, 2009; 50(9): 4386 - 4393.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Tian, Y. Zhou, D. Hajkova, M. Miyagi, A. Dinculescu, W. W. Hauswirth, K. Palczewski, R. Geng, K. N. Alagramam, J. Isosomppi, et al.
Clarin-1, Encoded by the Usher Syndrome III Causative Gene, Forms a Membranous Microdomain: POSSIBLE ROLE OF CLARIN-1 IN ORGANIZING THE ACTIN CYTOSKELETON
J. Biol. Chem., July 10, 2009; 284(28): 18980 - 18993.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. G. Jacobson, T. S. Aleman, A. Sumaroka, A. V. Cideciyan, A. J. Roman, E. A. M. Windsor, S. B. Schwartz, H. L. Rehm, and W. J. Kimberling
Disease Boundaries in the Retina of Patients with Usher Syndrome Caused by MYO7A Gene Mutations
Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1886 - 1894.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. V. Cideciyan, M. Swider, T. S. Aleman, Y. Tsybovsky, S. B. Schwartz, E. A.M. Windsor, A. J. Roman, A. Sumaroka, J. D. Steinberg, S. G. Jacobson, et al.
ABCA4 disease progression and a proposed strategy for gene therapy
Hum. Mol. Genet., March 1, 2009; 18(5): 931 - 941.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Association for Research in Vision and Ophthalmology